Metropolitan Life Insurance Company (MetLife)’s Acorda Therapeutics ACOR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-121	Closed	-$112K	–	2642
2019 Q2	$112K	Hold	121	–	–	﹤0.01%	2243
2019 Q1	$193K	Hold	121	–	–	﹤0.01%	1916
2018 Q4	$227K	Hold	121	–	–	﹤0.01%	1730
2018 Q3	$286K	Hold	121	–	–	﹤0.01%	1746
2018 Q2	$417K	Hold	121	–	–	0.01%	1441
2018 Q1	$344K	Buy	121 +3	+3%	+$8.98K	﹤0.01%	1520
2017 Q4	$303K	Sell	118 -131	-53%	-$372K	﹤0.01%	1611
2017 Q3	$707K	Hold	249	–	–	﹤0.01%	1462
2017 Q2	$589K	Hold	249	–	–	﹤0.01%	1569
2017 Q1	$628K	Sell	249 -9	-3%	-$25.9K	﹤0.01%	1500
2016 Q4	$582K	Hold	258	–	–	﹤0.01%	1640
2016 Q3	$646K	Hold	258	–	–	﹤0.01%	1540
2016 Q2	$789K	Hold	258	–	–	0.01%	1400
2016 Q1	$819K	Buy	258 +8	+3%	+$33.2K	0.01%	1274
2015 Q4	$1.28M	Sell	250 -5	-2%	-$21.9K	0.01%	1058
2015 Q3	$813K	Hold	255	–	–	0.01%	1302
2015 Q2	$1.02M	Sell	255 -14	-5%	-$54.1K	0.01%	1269
2015 Q1	$1.07M	Sell	269 -1	-0.4%	-$4.58K	0.01%	1167
2014 Q4	$1.33M	Hold	270	–	–	0.01%	1160
2014 Q3	$1.1M	Hold	270	–	–	0.01%	1218
2014 Q2	$1.09M	Hold	270	–	–	0.01%	1294
2014 Q1	$1.23M	Hold	270	–	–	0.01%	1206
2013 Q4	$948K	Hold	270	–	–	0.01%	1366
2013 Q3	$1.11M	Hold	270	–	–	0.01%	1223
2013 Q2	$1.07M	Buy	+270	New	+$1.11M	0.01%	1192

Other funds holding ACOR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACOR Position: Q3 2019 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Acorda Therapeutics (ACOR) in Q3 2019, closing a stake of 121 shares — an estimated $112K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACOR in Q2 2013 and held it in 25 quarters. The position peaked at $1.33M in Q4 2014. 151 funds tracked by Wall St. Rank hold ACOR as of Q3 2019.

Metropolitan Life Insurance Company (MetLife) reported no remaining Acorda Therapeutics position as of Q3 2019 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 121 Acorda Therapeutics shares in Q3 2019, an estimated $112K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Acorda Therapeutics in Q2 2013 and held it in 25 quarters.
Metropolitan Life Insurance Company (MetLife)'s Acorda Therapeutics position peaked at $1.33M in Q4 2014.
151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2019.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2019, filed 14 Nov 2019.